1. Home
  2. OSUR vs MGTX Comparison

OSUR vs MGTX Comparison

Compare OSUR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.40

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$8.05

Market Cap

744.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
MGTX
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.2M
744.9M
IPO Year
1986
N/A

Fundamental Metrics

Financial Performance
Metric
OSUR
MGTX
Price
$2.40
$8.05
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$3.00
$23.83
AVG Volume (30 Days)
742.3K
643.1K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$125,703,000.00
$27,417,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.70
$619.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
96.83
52 Week Low
$2.08
$4.55
52 Week High
$4.22
$9.73

Technical Indicators

Market Signals
Indicator
OSUR
MGTX
Relative Strength Index (RSI) 43.86 44.34
Support Level $2.41 $8.25
Resistance Level $2.53 $9.50
Average True Range (ATR) 0.11 0.56
MACD 0.01 -0.04
Stochastic Oscillator 15.52 21.32

Price Performance

Historical Comparison
OSUR
MGTX

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: